3B Blackbio [3BBLACKBIO] vs Dishman Carbogen [DCAL] Detailed Stock Comparison

3B Blackbio Diagnostics Ltd.

BSE
Loading...

Dishman Carbogen Amcis Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: 3B Blackbio Diagnostics Ltd. wins in 10 metrics, Dishman Carbogen Amcis Ltd. wins in 9 metrics, with 0 ties. 3B Blackbio Diagnostics Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric 3B Blackbio Diagnostics Ltd. Dishman Carbogen Amcis Ltd. Better
P/E Ratio (TTM) 20.80 22.30 3B Blackbio Diagnostics Ltd.
Price-to-Book Ratio 3.89 0.42 Dishman Carbogen Amcis Ltd.
Debt-to-Equity Ratio 0.09 40.20 3B Blackbio Diagnostics Ltd.
PEG Ratio 0.34 -0.16 3B Blackbio Diagnostics Ltd.
EV/EBITDA 20.17 9.62 Dishman Carbogen Amcis Ltd.
Profit Margin (TTM) 44.56% 4.25% 3B Blackbio Diagnostics Ltd.
Operating Margin (TTM) 42.39% 3.99% 3B Blackbio Diagnostics Ltd.
EBITDA Margin (TTM) 42.39% 3.99% 3B Blackbio Diagnostics Ltd.
Return on Equity 17.60% 0.06% 3B Blackbio Diagnostics Ltd.
Return on Assets (TTM) 16.13% 0.03% 3B Blackbio Diagnostics Ltd.
Free Cash Flow (TTM) $424.53M $1.58B Dishman Carbogen Amcis Ltd.
1-Year Return -24.89% -26.89% 3B Blackbio Diagnostics Ltd.
Price-to-Sales Ratio (TTM) 9.21 0.95 Dishman Carbogen Amcis Ltd.
Enterprise Value $11.32B $46.55B Dishman Carbogen Amcis Ltd.
EV/Revenue Ratio 8.78 1.66 Dishman Carbogen Amcis Ltd.
Gross Profit Margin (TTM) 72.47% 80.34% Dishman Carbogen Amcis Ltd.
Revenue per Share (TTM) $152 $179 Dishman Carbogen Amcis Ltd.
Earnings per Share (Diluted) $66.57 $7.58 3B Blackbio Diagnostics Ltd.
Beta (Stock Volatility) 0.47 0.40 Dishman Carbogen Amcis Ltd.

3B Blackbio Diagnostics Ltd. vs Dishman Carbogen Amcis Ltd. Stock Performance Analysis

Loading Price Chart...

3BBLACKBIO
DCAL

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
3B Blackbio Diagnostics Ltd.-0.73%-7.13%-9.11%-6.85%-11.83%-19.55%
Dishman Carbogen Amcis Ltd.-1.63%-1.29%4.71%18.97%-17.56%-23.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
3B Blackbio Diagnostics Ltd.-24.89%58.97%58.97%58.97%58.97%58.97%
Dishman Carbogen Amcis Ltd.-26.89%58.94%-7.70%27.01%314.26%123.54%

Performance & Financial Health Analysis: 3B Blackbio Diagnostics Ltd. vs Dishman Carbogen Amcis Ltd.

Metric3BBLACKBIODCAL
Market Information
Market Cap i₹11.13B₹26.50B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i12,508337,264
90 Day Avg. Volume i12,860517,904
Last Close₹1,129.75₹191.94
52 Week Range₹1,083.50 - ₹1,750.00₹128.50 - ₹321.95
% from 52W High-35.44%-40.38%
All-Time High₹2,350.00 (Dec 09, 2024)₹396.40 (Jan 22, 2018)
% from All-Time High-51.93%-51.58%
Growth Metrics
Quarterly Revenue Growth0.98%0.06%
Quarterly Earnings Growth0.62%-0.09%
Financial Health
Profit Margin (TTM) i0.45%0.04%
Operating Margin (TTM) i0.42%0.04%
Return on Equity (TTM) i0.18%0.00%
Debt to Equity (MRQ) i0.0940.20
Cash & Liquidity
Book Value per Share (MRQ)₹355.75₹405.67
Cash per Share (MRQ)₹27.44₹40.41
Operating Cash Flow (TTM) i₹619.97M₹-199,700,000
Levered Free Cash Flow (TTM) i₹476.91M₹32.40M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/A₹0.00

Valuation & Enterprise Metrics Analysis: 3B Blackbio Diagnostics Ltd. vs Dishman Carbogen Amcis Ltd.

Metric3BBLACKBIO (Apr 24, 2026)DCAL (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i20.8022.30
Forward P/E iN/A13.52
PEG Ratio i0.34-0.16
Price to Sales (TTM) i9.210.95
Price to Book (MRQ) i3.890.42
Market Capitalization
Market Capitalization i₹11.13B₹26.50B
Enterprise Value i₹11.32B₹46.55B
Enterprise Value Metrics
Enterprise to Revenue i8.781.66
Enterprise to EBITDA i20.179.62
Risk & Other Metrics
Beta i0.470.40
Book Value per Share (MRQ) i₹355.75₹405.67

Financial Statements Comparison: 3B Blackbio Diagnostics Ltd. vs Dishman Carbogen Amcis Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

Metric3BBLACKBIO (2025)DCAL (2025)
Revenue/Sales i964.69M26.42B
Cost of Goods Sold i256.46M5.26B
COGS % of Revenue i26.6%19.9%
Gross Profit i708.23M21.16B
Gross Margin i73.4%80.1%
Research & Development i5.12MN/A
Operating Income (EBIT) i493.22M1.46B
Operating Margin i51.1%5.5%
EBITDA i591.08M4.83B
EBITDA Margin i61.3%18.3%
Pre-Tax Income i639.98M193.10M
Pre-Tax Income % of Revenue i66.3%0.7%
Income Tax i163.07M160.70M
Income Tax % of Revenue i16.9%0.6%
Net Income (Profit) i476.91M32.40M
Profit Margin i49.4%0.1%

Balance Sheet & Liquidity Metrics

Metric3BBLACKBIO (2025)DCAL (2025)
Cash & Equivalents i117.07M2.86B
Total Current Assets i1.32B22.00B
Total Current Assets % of Revenue i137.0%83.3%
Total Current Liabilities i185.88M19.25B
Total Current Liabilities % of Revenue i19.3%72.9%
Long-Term Debt i3.07M13.90B
Long-Term Debt % of Revenue i0.3%52.6%
Total Shareholders Equity i2.71B58.32B
Retained Earnings i2.51B2.13B
Retained Earnings % of Revenue i259.9%8.1%
Property, Plant & Equipment i85.37M10.27B

Cash Flow Statement Comparison

Metric3BBLACKBIO (2025)DCAL (2025)
Operating Cash Flow i619.97M-199.70M
Operating Cash Flow % of Revenue i64.3%-0.8%
Capital Expenditures i-9.04M-2.15B
Free Cash Flow i424.53M1.58B
FCF Margin i44.0%6.0%
Debt Repayment i-5.44M-1.10B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

Metric3BBLACKBIODCAL
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i8.58M156.78M
Float Shares i2.69M54.95M
% Held by Insiders i65.90%69.30%
% Held by Institutions i1.95%2.41%
% Held by Public i32.15%28.29%

Dividend Analysis & Yield Comparison: 3B Blackbio Diagnostics Ltd. vs Dishman Carbogen Amcis Ltd.

Metric3BBLACKBIODCAL
Last 12-Month Dividend iN/A₹0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/A₹0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/A₹0.00
Ex-Dividend DateN/AN/A